Modeling Diversity in Cancer And Virus Evolution

Material Package

Added Since

Include only attachments uploaded after this date

Include*

Everything

Specific sessions

Specific contributions

Specific days

Sessions*

Welcome & Evening Lecture

Block A1

Session 1

Session 3

Session 2

Session 4

Session 5

Session 6

Session 7

Session 8

Session 9

Afterwards: Discussions

Include materials from selected sessions

Contributions*

A roadmap to precision medicine in breast cancer bone metastases (in session "Session 3")

Convergence in viral populations (in session "Session 4")

Detection of Immune-mediated negative selection using dN/dS (in session "Session 5")

Discussion: What can cancer evolution learn from virus dynamics? What can virus evolution learn from cancer dynamics? (in session "Session 8")

Estimating the mutational fitness effects distribution during early HIV infection (in session "Session 5")

Evolution of Clonal Heterogeneity in Chronic Myelomonocytic Leukemia (in session "Session 7")

Evolution of Competing Diversities: Tumor vs. Immune (in session "Session 3")

Evolution of resistance to ALK targeting therapies in NSCLC (in session "Session 3")

Experimental and Mathematical Modelling of Collateral Sensitivity in Heterogeneous Cancer Populations (in session "Session 2")

Exploring evolutionary trajectories of populations subjected to sequences of drugs in vitro (in session "Session 4")

Farewell

Front dynamics and evolution associated with spatial spread (in session "Session 7")

How do cellular selection and diversity contribute to leukemic progression? Seeking answers using computational and mathematical analyses (in session "Session 9")

Immunogenicity and tumor dormancy in brain metastases: comparison of central and peripheral markers of tumor dormancy in relation to NKG2DL expression (in session "Session 7")

In-depth characterization of a hallmark for balancing selection: HLA heterozygote advantage against HIV-1 (in session "Session 4")

Inferring clonal mutations from a spatial computational model of intratumour heterogeneity (in session "Session 2")

Keynote: Tibor Antal (in session "Session 8")

Learning and perturbing the evolutionary mechanisms driving therapeutic resistance in cancer (in session "Session 1")

Measuring evolutionary dynamics of human cancers from genomic data (in session "Session 6")

Pathways to resistance in growing populations over fitness valleys (in session "Session 5")

Personalized adaptive therapies for metastatic melanoma: A phase I approach (in session "Session 2")

Stopping treatment of CML in virtual patients (in session "Session 6")

The dynamics of adaptive genetic diversity during the early stages of clonal evolution (in session "Session 9")

The evolutionary history of colorectal cancers (in session "Session 1")

Include materials from selected contributions

Events scheduled on*

14/05/2018

15/05/2018

16/05/2018

17/05/2018

Include materials from sessions/contributions scheduled on the selected dates